# Heritage Insurance Holdings, Inc.: financial statements, quarterly

HRTG · NYSE · CIK 1598665 · [Financials](/sectors/financials.md)

Pages: [Overview](/companies/hrtg.md) · [Financials](/companies/hrtg/financials.md) · [Filings](/companies/hrtg/filings.md) · [Insiders](/companies/hrtg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hrtg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [186](/filings/0001598665-25-000009.md) | [187](/filings/0001598665-25-000009.md) | [191](/filings/0001193125-26-115451.md) | [204](/filings/0001193125-26-115451.md) | [212](/filings/0001193125-26-115451.md) | [210](/filings/0001193125-26-115451.md) | [212](/filings/0001193125-26-214067.md) | [208](/filings/0001193125-26-339815.md) | [212](/filings/0001193125-26-115451.md) | [215](/filings/0001193125-26-115451.md) | [213](/filings/0001193125-26-214067.md) | [214](/filings/0001193125-26-339815.md) |
| Selling, general and administrative | $m | [21.9](/filings/0001598665-24-000014.md) | [16.8 d](/filings/0001193125-26-115451.md) | [19.6](/filings/0001598665-25-000027.md) | [22.8](/filings/0001598665-25-000058.md) | [21.6](/filings/0001598665-25-000076.md) | [21.2 d](/filings/0001193125-26-115451.md) | [23.9](/filings/0001193125-26-214067.md) | [24.4](/filings/0001193125-26-339815.md) | [22.3](/filings/0001598665-25-000076.md) | [22.4 d](/filings/0001193125-26-115451.md) | [24.9](/filings/0001193125-26-214067.md) | [23.8](/filings/0001193125-26-339815.md) |
| Operating income | $m | [(9.4)](/filings/0001598665-25-000009.md) | [36.2](/filings/0001598665-25-000009.md) | [22.7](/filings/0001193125-26-115451.md) | [27.6](/filings/0001193125-26-115451.md) | [11.7](/filings/0001193125-26-115451.md) | [31.5](/filings/0001193125-26-115451.md) | [42.4](/filings/0001193125-26-214067.md) | [64.9](/filings/0001193125-26-339815.md) | [70.2](/filings/0001193125-26-115451.md) | [89.7](/filings/0001193125-26-115451.md) | [50.8](/filings/0001193125-26-214067.md) | [83.9](/filings/0001193125-26-339815.md) |
| Interest expense | $m | [2.6](/filings/0001598665-24-000014.md) | [3.0 d](/filings/0001193125-26-115451.md) | [2.8](/filings/0001598665-25-000027.md) | [2.8](/filings/0001598665-25-000058.md) | [2.8](/filings/0001598665-25-000076.md) | [2.6 d](/filings/0001193125-26-115451.md) | [2.4](/filings/0001193125-26-214067.md) | [1.9](/filings/0001193125-26-339815.md) | [1.9](/filings/0001598665-25-000076.md) | [1.7 d](/filings/0001193125-26-115451.md) | [1.8](/filings/0001193125-26-214067.md) | [1.7](/filings/0001193125-26-339815.md) |
| Income tax | $m | [(4.6)](/filings/0001598665-24-000014.md) | [2.2 d](/filings/0001193125-26-115451.md) | [5.6](/filings/0001598665-25-000027.md) | [6.0](/filings/0001598665-25-000058.md) | [0.8](/filings/0001598665-25-000076.md) | [8.7 d](/filings/0001193125-26-115451.md) | [9.5](/filings/0001193125-26-214067.md) | [15.0](/filings/0001193125-26-339815.md) | [17.9](/filings/0001598665-25-000076.md) | [21.3 d](/filings/0001193125-26-115451.md) | [12.6](/filings/0001193125-26-214067.md) | [20.5](/filings/0001193125-26-339815.md) |
| Net income | $m | [(7.4)](/filings/0001598665-25-000009.md) | [30.9](/filings/0001598665-25-000009.md) | [14.2](/filings/0001193125-26-115451.md) | [18.9](/filings/0001193125-26-115451.md) | [8.2](/filings/0001193125-26-115451.md) | [20.3](/filings/0001193125-26-115451.md) | [30.5](/filings/0001193125-26-339815.md) | [48.0](/filings/0001193125-26-339815.md) | [50.4](/filings/0001193125-26-115451.md) | [66.7](/filings/0001193125-26-115451.md) | [36.5](/filings/0001193125-26-339815.md) | [61.7](/filings/0001193125-26-339815.md) |
| Diluted EPS | $ per share | [(0.28)](/filings/0001598665-25-000009.md) | [1.15](/filings/0001598665-25-000009.md) | [0.47](/filings/0001193125-26-115451.md) | [0.61](/filings/0001193125-26-115451.md) | [0.27](/filings/0001193125-26-115451.md) | [0.66](/filings/0001193125-26-115451.md) | [0.99](/filings/0001193125-26-214067.md) | [1.55](/filings/0001193125-26-339815.md) | [1.63](/filings/0001193125-26-115451.md) | [2.15](/filings/0001193125-26-115451.md) | [1.19](/filings/0001193125-26-214067.md) | [2.05](/filings/0001193125-26-339815.md) |
| Basic EPS | $ per share | [(0.28)](/filings/0001598665-25-000009.md) | [1.15](/filings/0001598665-25-000009.md) | [0.47](/filings/0001193125-26-115451.md) | [0.62](/filings/0001193125-26-115451.md) | [0.27](/filings/0001193125-26-115451.md) | [0.66](/filings/0001193125-26-115451.md) | [0.99](/filings/0001193125-26-214067.md) | [1.55](/filings/0001193125-26-339815.md) | [1.63](/filings/0001193125-26-115451.md) | [2.16](/filings/0001193125-26-115451.md) | [1.19](/filings/0001193125-26-214067.md) | [2.06](/filings/0001193125-26-339815.md) |

- Revenue: us-gaap:Revenues
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [229](/filings/0000950170-23-059379.md) | [464](/filings/0001598665-25-000009.md) | [386](/filings/0000950170-24-055619.md) | [481](/filings/0001598665-24-000008.md) | [510](/filings/0001598665-24-000014.md) | [453](/filings/0001193125-26-115451.md) | [426](/filings/0001598665-25-000027.md) | [473](/filings/0001598665-25-000058.md) | [560](/filings/0001598665-25-000076.md) | [559](/filings/0001193125-26-339815.md) | [517](/filings/0001193125-26-214067.md) | [588](/filings/0001193125-26-339815.md) |
| Total assets | $m | [2,369](/filings/0000950170-23-059379.md) | [2,120](/filings/0001598665-25-000009.md) | [2,130](/filings/0000950170-24-055619.md) | [2,599](/filings/0001598665-24-000008.md) | [2,374](/filings/0001598665-24-000014.md) | [2,469](/filings/0001193125-26-115451.md) | [2,213](/filings/0001598665-25-000027.md) | [2,537](/filings/0001598665-25-000058.md) | [2,367](/filings/0001598665-25-000076.md) | [2,196](/filings/0001193125-26-339815.md) | [2,021](/filings/0001193125-26-214067.md) | [2,452](/filings/0001193125-26-339815.md) |
| Total liabilities | $m | [2,217](/filings/0000950170-23-059379.md) | [1,899](/filings/0001598665-25-000009.md) | [1,895](/filings/0000950170-24-055619.md) | [2,344](/filings/0001598665-24-000008.md) | [2,095](/filings/0001598665-24-000014.md) | [2,178](/filings/0001193125-26-115451.md) | [1,884](/filings/0001598665-25-000027.md) | [2,153](/filings/0001598665-25-000058.md) | [1,930](/filings/0001598665-25-000076.md) | [1,691](/filings/0001193125-26-339815.md) | [1,501](/filings/0001193125-26-214067.md) | [1,885](/filings/0001193125-26-339815.md) |
| Long-term debt | $m | [122](/filings/0000950170-23-059379.md) | [120](/filings/0001598665-25-000009.md) | [123](/filings/0000950170-24-055619.md) | [121](/filings/0001598665-24-000008.md) | [119](/filings/0001598665-24-000014.md) | [116](/filings/0001193125-26-115451.md) | [94.8](/filings/0001598665-25-000027.md) | [92.4](/filings/0001598665-25-000058.md) | [79.3](/filings/0001598665-25-000076.md) | [78.4](/filings/0001193125-26-339815.md) | [77.6](/filings/0001193125-26-214067.md) | [71.3](/filings/0001193125-26-339815.md) |
| Shareholders' equity | $m | [151](/filings/0001598665-24-000014.md) | [220](/filings/0001193125-26-115451.md) | [235](/filings/0001598665-25-000076.md) | [255](/filings/0001598665-25-000076.md) | [279](/filings/0001598665-25-000076.md) | [291](/filings/0001193125-26-339815.md) | [329](/filings/0001193125-26-339815.md) | [383](/filings/0001193125-26-339815.md) | [437](/filings/0001598665-25-000076.md) | [505](/filings/0001193125-26-339815.md) | [520](/filings/0001193125-26-339815.md) | [568](/filings/0001193125-26-339815.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(53.5) d](/filings/0001598665-24-000014.md) | [99.8 d](/filings/0001193125-26-115451.md) | [4.3](/filings/0001598665-25-000027.md) | [152 d](/filings/0001598665-25-000058.md) | [(13.4) d](/filings/0001598665-25-000076.md) | [(56.1) d](/filings/0001193125-26-115451.md) | [0.8](/filings/0001193125-26-214067.md) | [43.3 d](/filings/0001193125-26-339815.md) | [124 d](/filings/0001598665-25-000076.md) | [13.8 d](/filings/0001193125-26-115451.md) | [24.9](/filings/0001193125-26-214067.md) | [142 d](/filings/0001193125-26-339815.md) |
| Capital expenditure | $m | [2.4 d](/filings/0001598665-24-000014.md) | [1.4 d](/filings/0001193125-26-115451.md) | [0.2](/filings/0001598665-25-000027.md) | [2.5 d](/filings/0001598665-25-000058.md) | [3.0 d](/filings/0001598665-25-000076.md) | [2.6 d](/filings/0001193125-26-115451.md) | [2.1](/filings/0001193125-26-214067.md) | [1.5 d](/filings/0001193125-26-339815.md) | [1.6 d](/filings/0001598665-25-000076.md) | [2.9 d](/filings/0001193125-26-115451.md) | [1.8](/filings/0001193125-26-214067.md) | [0.7 d](/filings/0001193125-26-339815.md) |
| Dividends paid | $m | [0.0 d](/filings/0000950170-23-059379.md) | [0.0 d](/filings/0000950170-24-030766.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0000950170-23-059379.md) | [0.0 d](/filings/0001598665-25-000009.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [26.4](/filings/0000950170-23-059379.md) | [25.6](/filings/0000950170-24-055619.md) | [25.6](/filings/0001598665-24-000008.md) | [26.7](/filings/0001598665-24-000014.md) | [30.4](/filings/0001598665-25-000027.md) | [30.7](/filings/0001598665-25-000058.md) | [30.7](/filings/0001598665-25-000076.md) | [30.8](/filings/0001193125-26-214067.md) | [31.1](/filings/0001193125-26-339815.md) | [31.0](/filings/0001598665-25-000076.md) | [30.7](/filings/0001193125-26-214067.md) | [30.1](/filings/0001193125-26-339815.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 29,732,416 at 2026-08-02, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-339815.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.